View Clinical Trial (Medical Research Study)

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder - NCT00928070-63117(Clinical Trial 318792)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  St. Louis
State:  
MO
Zip Code: 63117
Conditions: Overactive Bladder
Purpose: This study is designed to assess the efficacy and safety of a flexible dose regimen of fesoterodine on urgency urinary incontinence (UUI) episodes in vulnerable elderly subjects with overactive bladder (OAB).
Study summary:
Criteria: Inclusion Criteria: - male or female subjects 65 years of age or older - OAB symptoms for at least 3 months - score 3 or greater on Vulnerable Elderly Survey (VES-13) - adequate mobility for independent toileting - mean number of at least 2 UUI episodes per 24 hours - mean urinary frequency of 8 or more micturitions per 24 hours - able to independently complete the bladder diaries Exclusion Criteria: - PVR urinary volume greater than 200 ml - MMSE score less than 20 - greater than 15 UUI episodes per 24 hours - creatinine clearance less than 30 ml/min - an average resting heart rate of greater than or equal to 90 beats per minute
Study is available at: Pfizer Investigational Site
St. Louis, MO 63117
United States

Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.